ALPS Medical Breakthroughs ETF SBIO
52.53 USD -0.37 (-0.71%)
Regular-session close
52.53 0.00 0.00%
Pre-market · Nov 20, 4:00 AM ET
52.25 Day range 53.85
45.65 52-week range 70.85
- YTD
- +2.56%
- 1 year
- +14.00%
ALPS Medical Breakthroughs ETF
- Issuer
- ALPS Funds
- Asset class
- Equity
- Expense ratio
- 0.50%
- Assets under management
- $180.57M
- NAV
- 53.90
- Holdings
- 103
- Inception
- 2014-12-30
- Top 10 weight
- 32.74%
Top holdings
- CGON CG oncology Inc. 4.76%
- ORKA Oruka Therapeutics Inc. 4.35%
- MANE VeraDermics Inc. 3.58%
- DNTH Dianthus Therapeutics Inc. 3.32%
- TVTX Travere Therapeutics Inc. 3.28%
- EWTX Edgewise Therapeutics Inc. 3.11%
- DFTX Definium Therapeutics Inc. 2.69%
- SLS SELLAS Life Sciences Group Inc. 2.64%
- XENE Xenon Pharmaceuticals Inc. 2.56%
- RLAY Relay Therapeutics Inc. 2.46%
- AMLX Amylyx Pharmaceuticals Inc. 2.36%
- TARS Tarsus Pharmaceuticals Inc. 2.34%
- VRDN Viridian Therapeutics Inc. 2.32%
- ACAD ACADIA Pharmaceuticals Inc. 2.15%
- DYN Dyne Therapeutics Inc. 2.04%
- VCEL Vericel Corp. 2.02%
- IRON Disc Medicine Inc. 2.00%
- DNLI Denali Therapeutics Inc. 1.96%
- ZLAB Zai Lab Ltd. 1.80%
- IDYA Ideaya Biosciences Inc. 1.80%
- XNCR Xencor Inc. 1.75%
- MBX MBX Biosciences Inc. 1.74%
- NAMS Newamsterdam Pharma Co. NV 1.58%
- LKFT Lakefront Biotherapeutics NV 1.56%
- CLDX Celldex Therapeutics Inc. 1.50%
Sector weights
- Healthcare 100.00%
Country weights
- United States 91.93%
- Canada 2.58%
- China 1.88%
- Netherlands 1.58%
- United Kingdom 1.51%
- Switzerland 0.31%
- Belgium 0.20%
Updated 2026-11-18
